Results 131 to 140 of about 246,562 (305)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

An interview with Regina Root

open access: yesAcervo, 2018
Regina A. Root (raroot@wm.edu) is Professor of Hispanic Studies at William & Mary, the historic university in Williamsburg, Virginia. She is an international expert known for her work on fashion, textiles, and Latin American cultural production.
Maria do Carmo Rainho   +1 more
doaj  

Exhibiting Fashion Symposium: Marie Riegels Melchior "Fashion and Dress Museology"

open access: yes
The Museum at FIT presented Exhibiting Fashion, its twenty-first academic symposium on Friday, March 8, 2019. This symposium explored the history of fashion curating, the different ways fashion is displayed in museum settings, and how national and ...

core  

Urban fashion policies: lessons from the Barcelona catwalks [PDF]

open access: yes
Since at least a decade, Barcelona is on the world map of fashion: Antonio Mirò, Mango, Desigual, Agatha Ruiz de la Prada are famous Barcelona-based stylists teaming up with other large Spanish fashion firms, like Zara, and commercial outlets, like El ...
Chilese Erica, Russo Antonio Paolo
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

James Gager at the Queer History of Fashion Symposium

open access: yes
James Gager, senior vice president and creative director for MAC Cosmetics, presents "MAC: All Ages, All Races, All Sexes" at The Museum at FIT's 13th fashion symposium, A Queer History of Fashion, held November 8-9, 2013.

core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Rapunzel Syndrome complicated by dual jejuno-jejunal intussusceptions: a case report. [PDF]

open access: yesInt J Surg Case Rep
Abed V   +5 more
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy